Medicine guide

Forsteo 250 μg/mL

As listed in the register: Forsteo 250 μg/mL, solution injectable en stylo prérempli

250 μg/mL ·

  • Prescription only
  • Hormones, such as thyroid and steroids
Active substance
Teriparatidum ADNr
Made by
Eli Lilly (Suisse) SA

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

  • Femmes présentant une ostéoporose postménopausique; hommes présentant une ostéoporose primaire ou due à un hypogonadisme. Ostéoporose induite par les glucocorticoïdes chez les adultes avec un risque accru de fracture.

From the official label · 2026-09-30 · Swissmedic

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

BulgariaNo exact match for this strength and form

European UnionNo exact match for this strength and form

SpainNo exact match for this strength and form

CanadaNo exact match for this strength and form

NetherlandsNo exact match for this strength and form

Details

Made byEli Lilly (Suisse) SA
Active substanceTeriparatidum ADNr
Used inHormones, such as thyroid and steroids
Strength250 μg/mL
ClassificationH05AA02 · Hormones, such as thyroid and steroids
Dispensing (as stated by the register)Abgabekategorie B
Name in the registerForsteo 250 μg/mL, solution injectable en stylo prérempli
Packs1 Stück
Zulassungsnummer56007
Dosisstärke1

Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician

Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.